Feasibility and results of a randomized phase Ib study of fractionated 90{Upsilon}-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies Meeting Abstract
| Authors: | Picozzi, V. J.; Ramanathan, R. K.; Lowery, M. A.; Ocean, A. J.; Mitchell, E. P.; O'Neil, B. H.; Guarino, M. J.; Conkling, P. R.; Cohen, S. J.; Bahary, N.; Frank, R. C.; Dragovich, T.; Bridges, B. B.; Braiteh, F. S.; Lee, F. C.; Gribbin, T. E.; Richards, D. A.; Starodub, A.; Wegener, W. A.; Goldenberg, D. M. |
| Abstract Title: | Feasibility and results of a randomized phase Ib study of fractionated 90{Upsilon}-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203189 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4026 |
| Notes: | Meeting Abstract: 4026 -- Source: Wos |
